Showing results (51-60 of 70) with videos related to
Sort By:
Pageof 7
Frontiers in Oncology|July 22, 2024
A phase Ib study to assess the safety of the human papillomavirus DNA vaccine (AMV002) in combination with durvalumab for HPV-associated oropharyngeal squamous cell carcinomaRahul Ladwa, Janin Chandra, Wai-Ping Woo, et al.Journal of Translational Medicine|July 25, 2024
Spatial dynamics of tertiary lymphoid aggregates in head and neck cancer: insights into immunotherapy responseHabib Sadeghirad, James Monkman, Chin Wee Tan, et al.Pathology|August 12, 2023
Implementing structured pathology reporting protocol for non-melanocytic skin cancers: practical considerationsRuta Gupta, Christina I Selinger, Bruce Ashford, et al.Frontiers in Immunology|May 8, 2023
Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapyHabib Sadeghirad, Ning Liu, James Monkman, et al.International Journal of Cancer|January 18, 2020
Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: Beyond an era of chemoradiation?Liam Masterson, James Howard, Jazmina Gonzalez-Cruz, et al.Clinical Lung Cancer|August 27, 2022
A Multi-Center Real-World Experience of IMpower150 in Oncogene Driven Tumors and CNS MetastasesMalinda Itchins, Hannah Ainsworth, Marliese Alexander, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2025
Response-Adapted Surgical and Radiotherapy De-Escalation in Resectable Cutaneous Squamous Cell Cancer Using Pembrolizumab: The De-Squamate StudyRahul Ladwa, Jenny H Lee, Margaret McGrath, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2025
Randomized Phase Ib Clinical Trial of DB-020 Intratympanic Injections to Reduce High-Dose Cisplatin OtotoxicityBenedict J Panizza, Stephen John O'Leary, Christopher David Hart, et al.Journal of Translational Medicine|February 12, 2025
Spatial interaction mapping of PD-1/PD-L1 in head and neck cancer reveals the role of macrophage-tumour barriers associated with immunotherapy responseVahid Yaghoubi Naei, Rafael Tubelleza, James Monkman, et al.BMJ Open|May 16, 2022
Telehealth cancer-related fatigue clinic model for cancer survivors: a pilot randomised controlled trial protocol (the T-CRF trial)Rahul Ladwa, Elizabeth P Pinkham, Laisa Teleni, et al.Pageof 7